Veklury Gets EMA All-Clear Over Kidney Problems, But Faces New Safety Review For Bradycardia
Obesity Medicine Amfepramone Also Under The Safety Spotlight
Executive Summary
The pharmacovigilance panel at the European Medicines Agency is examining a new safety signal associated with Gilead’s COVID-19 antiviral therapy.